FR3617M - Applications pharmacologiques de nouveaux dérivés de la pyridazine notamment comme agents actifs contre les bactéries du favus. - Google Patents

Applications pharmacologiques de nouveaux dérivés de la pyridazine notamment comme agents actifs contre les bactéries du favus.

Info

Publication number
FR3617M
FR3617M FR968661A FR968661A FR3617M FR 3617 M FR3617 M FR 3617M FR 968661 A FR968661 A FR 968661A FR 968661 A FR968661 A FR 968661A FR 3617 M FR3617 M FR 3617M
Authority
FR
France
Prior art keywords
favus
bacteria
active agents
agents against
pyridazine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR968661A
Other languages
English (en)
Inventor
Tsutomu Irikura
Shimao Sato
Kazunari Shirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of FR3617M publication Critical patent/FR3617M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
FR968661A 1963-04-26 1964-03-25 Applications pharmacologiques de nouveaux dérivés de la pyridazine notamment comme agents actifs contre les bactéries du favus. Expired FR3617M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2189163 1963-04-26

Publications (1)

Publication Number Publication Date
FR3617M true FR3617M (fr) 1965-10-18

Family

ID=12067717

Family Applications (1)

Application Number Title Priority Date Filing Date
FR968661A Expired FR3617M (fr) 1963-04-26 1964-03-25 Applications pharmacologiques de nouveaux dérivés de la pyridazine notamment comme agents actifs contre les bactéries du favus.

Country Status (5)

Country Link
US (1) US3485838A (fr)
CH (1) CH431542A (fr)
DE (1) DE1445978B1 (fr)
FR (1) FR3617M (fr)
GB (1) GB997400A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966928A (en) * 1971-12-13 1976-06-29 Colgate-Palmolive Company Novel derivatives of pyridazine-2-oxide
US20040242886A1 (en) * 2003-04-30 2004-12-02 Sandeep Gupta Monocyclic diazodioxide based Bcl-2 protein antagonists related applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3169848A (en) * 1955-12-21 1965-02-16 Geigy Ag J R Composition and method for inhibiting the growth of plants

Also Published As

Publication number Publication date
GB997400A (en) 1965-07-07
DE1445978B1 (de) 1969-12-04
CH431542A (de) 1967-03-15
US3485838A (en) 1969-12-23

Similar Documents

Publication Publication Date Title
FR1761M (fr) Nouvelle pyridine, utilisable en thérapeutique, notamment comme antimycotique et désinfectant.
FR3617M (fr) Applications pharmacologiques de nouveaux dérivés de la pyridazine notamment comme agents actifs contre les bactéries du favus.
FR2075M (fr) Nouveaux dérivés de la 6-méthyl- et de la 1,6-diméthyl-ergoline i.
FR3529M (fr) Nouveau dérivé de l'acide anthranilique utilisable en thérapeutique, notamment comme agent anti-inflammatoire.
FR1910M (fr) Nouvelle hydrazone guanylique, utilisable en thérapeutique, comme agent anti-inflammatoire.
FR2790M (fr) Nouveaux dérivés des thiachromanes.
FR2692M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR1286939A (fr) Groupe d'éclaircissage de plants, notamment de betteraves
FR2598M (fr) Nouveaux dérivés de l'acide anthrauilique, utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR1309186A (fr) Siège, notamment siège de véhicule
FR3343M (fr) Agents thérapeutiques contre la toux appartenant au groupe des xanthénols.
FR1769M (fr) Nouveaux dérivés de la pipérazine.
FR3267M (fr) Nouveaux dérivés de la diphénylpropylamine utilisables comme médicaments.
FR1745M (fr) Nouvelle hydrazone guanylique, utilisable en thérapeutique, notamment comme agent anti-inflammatoire.
FR1405781A (fr) Nouveaux dérivés de l'urée utilisables, en particulier, comme émulsionnants
FR1727M (fr) Nouvelle hydrazone guanylique, utilisable en thérapeutique, notamment comme anti-inflammatoire.
FR2067M (fr) Nouveaux hydrazides utilisables en thérapeutique, notamment comme agents antibactériens.
FR1939M (fr) Nouveaux dérivés de tétrahydroisoquinoléine.
FR3768M (fr) Médicament utilisable en dermatologie notamment contre les infections virales.
FR1374058A (fr) Nouveaux polyesters, notamment de l'acide 1.4-bicyclo[2.2.2]octane-dicarboxylique
OA01370A (fr) Compositions contenant du bis-diméthylacrylate de cuivre, utilisables notamment comme fongicides.
FR1350843A (fr) Nouveaux profilés, utilisables notamment pour la bordure des meubles
FR2724M (fr) Oxapregn-4-ene-3,20-diones éventuellement 6-méthylées et leurs dérivés apparentés notamment a-homo, utiles comme agents progestatifs.
FR1067M (fr) Nouveaux dérivés de la cyclopropyl-5-hydantoine.
BE801727A (fr) Derives du benzimidazole leur preparation et leurs applications notamment comme agents fongicides